60
Participants
Start Date
October 31, 2023
Primary Completion Date
January 31, 2024
Study Completion Date
January 31, 2024
Salivary Sampling
"Inclusion visit: After signature of the informed consent, all subjects will perform 3 consecutive Endotest® Diagnostic during the visit and 1 at-home.~Circadian circle visit: 6 included subjects will be asked to come back for a full day. They will have to perform 17 Endotest® Diagnostic: 14 on study site and 3 at home after the visit.~Repeatability-intermediate fidelity-stability-interferences visit: a maximum of 16 included subjects will be asked to come back for this visit. They will have to perform 17 Endotest® Diagnostic: 14 on study site and 3 at home after the visit."
Clinique Tivoli, Bordeaux
CHU de Rouen, Rouen
Lead Sponsor
Monitoring Force Group
INDUSTRY
ZIWIG
INDUSTRY